Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Influenza Virus

NCT05378022 is registered in ClinicalTrials.gov with National Children's Hospital, Vietnam as lead sponsor.

NCT NCT05378022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05378022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of LiveSpo Navax in Treatment of Acute Respiratory Disease in Children Infected With Influenza Virus
Lead sponsor
National Children's Hospital, Vietnam
Phase
Not applicable
Overall status
Completed
Start date
December 21, 2020
Completion date
April 22, 2022
Enrollment
70 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory tract infections